Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-07-18 5:42 pm Purchase | 13D | TELESIS BIO INC TBIO | Northpond Ventures LP | 1,034,546 47.7% | 1,672 (+0.16%) | View |
| 2024-06-10 8:40 pm Sale | 13D | TELESIS BIO INC TBIO | Northpond Ventures LP | 1,032,874 47.6% | -17,273,999 (-94.36%) | View |
| 2023-06-23 5:10 pm Sale | 13D | DICE Therapeutics Inc. DICE | Northpond Ventures LP | 800,000 1.7% | -2,492,871 (-75.71%) | View |
| 2023-06-15 4:15 pm Sale | 13D | IsoPlexis Corp ISO | Northpond Ventures LP | 0 0% | -8,808,531 (Position Closed) | View |
| 2023-06-07 5:00 pm Purchase | 13D | TELESIS BIO INC TBIO | Northpond Ventures LP | 18,306,873 47.9% | 8,462,743 (+85.97%) | View |
| 2023-04-18 9:45 pm Unchanged | 13D | TELESIS BIO INC TBIO | Northpond Ventures LP | 9,844,130 33.2% | 0 (Unchanged) | View |
| 2023-03-29 4:02 pm Purchase | 13G | Bruker Cellular Analysis Inc. CELL | Northpond Ventures LP | 5,390,820 5.6% | 5,390,820 (New Position) | View |
| 2022-12-21 7:06 pm Unchanged | 13D | IsoPlexis Corp ISO | Northpond Ventures LP | 8,808,531 22.3% | 0 (Unchanged) | View |
| 2022-12-16 5:22 pm Unchanged | 13D | VIGIL NEUROSCIENCE INC VIGL | Northpond Ventures LP | 4,214,498 11.8% | 0 (Unchanged) | View |
| 2022-11-10 4:15 pm Unchanged | 13D | DICE Therapeutics Inc. DICE | Northpond Ventures LP | 3,292,871 6.9% | 0 (Unchanged) | View |
| 2022-02-14 4:40 pm Purchase | 13G | CANDEL THERAPEUTICS INC CADL | Northpond Ventures LP | 1,935,215 6.7% | 1,935,215 (New Position) | View |
| 2022-01-19 4:25 pm Purchase | 13D | VIGIL NEUROSCIENCE INC VIGL | Northpond Ventures LP | 4,214,498 14.9% | 4,214,498 (New Position) | View |
| 2021-10-22 4:28 pm Purchase | 13D | IsoPlexis Corp ISO | Northpond Ventures LP | 8,808,531 22.7% | 8,808,531 (New Position) | View |
| 2021-09-28 06:04 am Purchase | 13D | DICE Therapeutics Inc. DICE | Northpond Ventures LP | 3,292,871 9.1% | 3,292,871 (New Position) | View |
| 2021-07-01 5:16 pm Purchase | 13D | TELESIS BIO INC TBIO | Northpond Ventures LP | 9,844,130 33.7% | 9,844,130 (New Position) | View |